Mushrooms are used in traditional Chinese medicine to treat a variety of diseases. Grifola frondosa (GF) is an edible mushroom indigenous to many Asian countries with a large fruiting body characterized by overlapping caps. In particular, GF is known for its anti-tumor activity, which has been targeted by scientific and clinical research. This study aimed to investigate the effects of the cold-water extract of GF (GFW) and its active fraction (GFW-GF) on autophagy and apoptosis, and the underlying mechanisms in vitro and in vivo. Our results revealed that GFW and GFW-GF inhibited phosphatidylinositol 3-kinase (PI3K) and stimulated c-Jun N-terminal kinase (JNK) pathways, thereby inducing autophagy. We also demonstrated that GFW and GFW-GF inhibited proliferation, induced cell cycle arrest, and apoptosis in Hep3B hepatoma cells. GFW and GFW-GF markedly arrested cells in S phase and promoted cleavage of caspase-3 and -9. In addition, GFW and GFW-GF decreased the expression levels of the anti-apoptotic proteins protein kinase B and extracellular signal-regulated kinase. We also found that GFW significantly inhibited tumor growth in nude mice implanted with Hep3B cells. Our work demonstrates that GF and its active fraction inhibit hepatoma growth by inducing autophagy and apoptosis.
TsuchiyaMKonoHMatsudaMFujiiHRusynI. Protective effect of Juzen-taiho-to on hepatocarcinogenesis is mediated through the inhibition of Kupffer cell-induced oxidative stress. Int J Cancer2008; 123: 2503–11.
2.
InoueHSeitzHK. Viruses and alcohol in the pathogenesis of primary hepatic carcinoma. Eur J Cancer Prev2001; 10: 107–10.
3.
KountourasJLygidakisNJ. New epidemiological data on liver oncogenesis. Hepatogastroenterology2000; 47: 855–61.
4.
BlonskiWKotlyarDSFordeKA. Non-viral causes of hepatocellular carcinoma. World J Gastroenterol2010; 16: 3603–15.
5.
El-SeragHBRudolphKL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology2007; 132: 2557–76.
6.
WatsonRW. The rising incidence of hepatocellular carcinoma. N Engl J Med1999; 341: 451–2.
7.
JemalASiegelRWardEHaoYXuJThunMJ. Cancer statistics, 2009. CA Cancer J Clin2009; 59: 225–49.
8.
TianAWilsonGSLieSWuGHuZHebbardLHebbardLDuanWGeorgeJQiaoL. Synergistic effects of IAP inhibitor LCL161 and paclitaxel on hepatocellular carcinoma cells. Cancer Lett2014; 351: 232–41.
9.
CuneoKCDavisMAFengMUNovelliPMEnsmingerWDLawrenceTS. Low dose rate radiosensitization of hepatocellular carcinoma in vitro and in patients. Transl Oncol2014; 7: 472–8.
10.
MarinelliSGranitoAPiscagliaFRenzulliMStagniABolondiL. Metronomic capecitabine in patients with hepatocellular carcinoma unresponsive to or ineligible for sorafenib treatment: report of two cases. Hepat Mon2013; 13: e11721–e11721.
11.
MayellM. Maitake extracts and their therapeutic potential. Altern Med Rev2001; 6: 48–60.
12.
KuboKNanbaH. Anti-hyperliposis effect of maitake fruit body (Grifola frondosa). I. Biol Pharm Bull1997; 20: 781–5.
13.
KonnoSTortorelisDGFullertonSASamadiAAHettiarachchiJTazakiH. A possible hypoglycaemic effect of maitake mushroom on Type 2 diabetic patients. Diabet Med2001; 18: 1010–1010.
14.
GuCQLiJWChaoFJinMWangXWShenZQ. Isolation, identification and function of a novel anti-HSV-1 protein from Grifola frondosa. Antiviral Res2007; 75: 250–7.
15.
MasudaYMatsumotoAToidaTOikawaTItoKNanbaH. Characterization and antitumor effect of a novel polysaccharide from Grifola frondosa. J Agric Food Chem2009; 57: 10143–9.
16.
MasudaYInoueHOhtaHMiyakeAKonishiMNanbaH. Oral administration of soluble beta-glucans extracted from Grifola frondosa induces systemic antitumor immune response and decreases immunosuppression in tumor-bearing mice. Int J Cancer2013; 133: 108–19.
17.
LiCWuXZhangHYangGHaoMShengSSunYLongJHuCSunXLiLZhengJ. A Huaier polysaccharide inhibits hepatocellular carcinoma growth and metastasis. Tumour Biol2014; 36: 1739–45.
18.
KerrJFWyllieAHCurrieAR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer1972; 26: 239–57.
19.
LiuZOuyangLPengHZhangWZ. Oridonin: targeting programmed cell death pathways as an anti-tumour agent. Cell Prolif2012; 45: 499–507.
LawBYChanWKXuSWWangJRBaiLPLiuLWongVK. Natural small-molecule enhancers of autophagy induce autophagic cell death in apoptosis-defective cells. Sci Rep2014; 4: 5510–5510.
22.
CarewJSKellyKRNawrockiST. Autophagy as a target for cancer therapy: new developments. Cancer Manag Res2012; 4: 357–65.
23.
ShimizuSYoshidaTTsujiokaMArakawaS. Autophagic cell death and cancer. Int J Mol Sci2014; 15: 3145–53.
24.
ZhouZWLiXXHeZXPanSTYangYZhangXChowKYangTQiuJXZhouQTanJWangDZhouSF. Induction of apoptosis and autophagy via sirtuin1- and PI3K/Akt/mTOR-mediated pathways by plumbagin in human prostate cancer cells. Drug Des Devel Ther2015; 9: 1511–54.
25.
DegtyarevMDe MaziereAOrrCLinJLeeBBTienJYPriorWWvan DijkSWuHGrayDCDavisDPStemHMMurrayLJHoeflichKPKlumpermanJFriedmanLSLinK. Akt inhibition promotes autophagy and sensitizes PTEN-null tumors to lysosomotropic agents. J Cell Biol2008; 183: 101–16.
26.
MaycottePThorburnA. Autophagy and cancer therapy. Cancer Biol Ther2011; 11: 127–37.
27.
KondoYKondoS. Autophagy and cancer therapy. Autophagy2006; 2: 85–90.
28.
WeingerKBeverlyEASmaldoneA. Diabetes self-care and the older adult. West J Nurs Res2014; 36: 1272–98.
29.
HuKHLiWXSunMYZhangSBFanCXWuQZhuWXuX. Cadmium induced apoptosis in MG63 cells by increasing ROS, activation of p38 MAPK and inhibition of ERK 1/2 pathways. Cell Physiol Biochem2015; 36: 642–54.
30.
GuoYChangHLiJXuXYShenLYuZBLiuWC. Thymosin alpha 1 suppresses proliferation and induces apoptosis in breast cancer cells through PTEN-mediated inhibition of PI3K/Akt/mTOR signaling pathway. Apoptosis2015; 20: 1109–21.
31.
GongKChenCZhanYChenYHuangZLiW. Autophagy-related gene 7 (ATG7) and reactive oxygen species/extracellular signal-regulated kinase regulate tetrandrine-induced autophagy in human hepatocellular carcinoma. J Biol Chem2012; 287: 35576–88.
32.
KungCPBudinaABalaburskiGBergenstockMKMurphyM. Autophagy in tumor suppression and cancer therapy. Crit Rev Eukaryot Gene Expr2011; 21: 71–100.
33.
TanidaIUenoTKominamiE. LC3 and autophagy. Methods Mol Biol2008; 445: 77–88.
34.
SinghBNKumarDShankarSSrivastavaRK. Rottlerin induces autophagy which leads to apoptotic cell death through inhibition of PI3K/Akt/mTOR pathway in human pancreatic cancer stem cells. Biochem Pharmacol2012; 84: 1154–63.
35.
Palmeira dos SantosCPereiraGJBarbosaCMJurkiewiczASmailiSSBincolettoC. Comparative study of autophagy inhibition by 3MA and CQ on cytarabineinduced death of leukaemia cells. J Cancer Res Clin Oncol2014; 140: 909–20.
36.
JemalABrayFCenterMMFerlayJWardEFormanD. Global cancer statistics. CA Cancer J Clin2011; 61: 69–90.
37.
HuangWYCaiYZZhangY. Natural phenolic compounds from medicinal herbs and dietary plants: potential use for cancer prevention. Nutr Cancer2010; 62: 1–20.
38.
HongLXunMWutongW. Anti-diabetic effect of an alpha-glucan from fruit body of maitake (Grifola frondosa) on KK-Ay mice. J Pharm Pharmacol2007; 59: 575–82.
39.
ShomoriKYamamotoMArifukuITeramachiKItoH. Antitumor effects of a water-soluble extract from Maitake (Grifola frondosa) on human gastric cancer cell lines. Oncol Rep2009; 22: 615–20.
40.
WesaKMCunningham-RundlesSKlimekVMVertosickEColetonMIYeungKSLinHNimerSCassilethBR. Maitake mushroom extract in myelodysplastic syndromes (MDS): a phase II study. Cancer Immunol Immunother2015; 64: 237–47.
41.
MasudaYItoKKonishiMNanbaH. A polysaccharide extracted from Grifola frondosa enhances the anti-tumor activity of bone marrow-derived dendritic cell-based immunotherapy against murine colon cancer. Cancer Immunol Immunother2010; 59: 1531–41.
42.
DengGLinHSeidmanAFornierMD’AndreaGWesaKYeungSCunningham-RundlesSVickersAJCassilethB. A phase I/II trial of a polysaccharide extract from Grifola frondosa (Maitake mushroom) in breast cancer patients: immunological effects. J Cancer Res Clin Oncol2009; 135: 1215–21.
43.
LinJTLiuWH. o-Orsellinaldehyde from the submerged culture of the edible mushroom Grifola frondosa exhibits selective cytotoxic effect against Hep 3B cells through apoptosis. J Agric Food Chem2006; 54: 7564–9.
44.
TzianabosAO. Polysaccharide immunomodulators as therapeutic agents: structural aspects and biologic function. Clin Microbiol Rev2000; 13: 523–33.
45.
MaXZhouFChenYZhangYHouLCaoXWangC. A polysaccharide from Grifola frondosa relieves insulin resistance of HepG2 cell by Akt-GSK-3 pathway. Glycoconj J2014; 31: 355–63.
46.
SiddhantaAKGoswamiAMRamavatBKModyHKMairhOP. Water soluble polysaccharides of marine algal species of Ulva (Ulvales, Chlorophyta) of Indian waters. Indian J Mar Sci2001; 30: 166–72.
47.
PalaciosIGuillamonEGarcia-LafuenteAVillaresA. Structural characterization of water-soluble polysaccharides from the fruiting bodies of lentinus edodes mushrooms. Curr Nutr Food Sci2012; 12: 235–41.
48.
LiuJWillförSXuC. A review of bioactive plant polysaccharides: biological activities, functionalization, and biomedical applications. Bioact Carbohydr Dietary Fibre2015; 5: 31–61.
49.
WangJHuSNieSYuQXieM. Reviews on mechanisms of in vitro antioxidant activity of polysaccharides. Oxid Med Cell Longev2016; 2016: 5692852–5692852.
50.
PaulIJonesJM. Apoptosis block as a barrier to effective therapy in non small cell lung cancer. World J Clin Oncol2014; 5: 588–94.
51.
GaoYShenJKMilaneLHornicekFJAmijiMMDuanZ. Targeted cancer therapy; nanotechnology approaches for overcoming drug resistance. Curr Med Chem2015; 22: 1335–47.
52.
McIlwainDRBergerTMakTW. Caspase functions in cell death and disease. Cold Spring Harb Perspect Biol2013; 5: a008656–a008656.
53.
LakhaniSAMasudAKuidaKPorterGAJrBoothCJMehalWZInayatIFlavellRA. Caspases 3 and 7: key mediators of mitochondrial events of apoptosis. Science2006; 311: 847–51.
54.
KlionskyDJEmrSD. Autophagy as a regulated pathway of cellular degradation. Science2000; 290: 1717–21.
55.
LiPShiJHeQHuQWangYYZhangLJChanWTChenWX. Streptococcus pneumoniae induces autophagy through the inhibition of the PI3K-I/Akt/mTOR pathway and ROS hypergeneration in A549 cells. PLoS ONE2015; 10: e0122753–e0122753.
56.
ShimizuSKonishiANishidaYMizutaTNishinaHYamamotoATsujimotoY. Involvement of JNK in the regulation of autophagic cell death. Oncogene2010; 29: 2070–82.
57.
WongCHIskandarKBYadavSKHirparaJLLohTPervaizS. Simultaneous induction of non-canonical autophagy and apoptosis in cancer cells by ROS-dependent ERK and JNK activation. PLoS ONE2010; 5: e9996–e9996.
58.
MarinoGNiso-SantanoMBaehreckeEHKroemerG. Self-consumption: the interplay of autophagy and apoptosis. Nat Rev Mol Cell Biol2014; 15: 81–94.
59.
TroianiTSchettinoCMartinelliEMorgilloFTortoraGCiardielloF. The use of xenograft models for the selection of cancer treatments with the EGFR as an example. Crit Rev Oncol Hematol2008; 65: 200–11.
